[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338488-105":59,"doc-detail-338488-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","cancer-incidence-and-mortality-among-patients-with-new-onset-atrial-fibrillation-a-population-based-matched-cohort-study","Cancer incidence and mortality among patients with new-onset atrial fibrillation - A population-based matched cohort study","","Understanding cancer risk after diagnosis of another condition creates opportunities for earlier detection. This matched-cohort study assessed cancer diagnosis and cancer mortality following prior new-onset atrial fibrillation (AF), using linked electronic health records for adults ≥18, with age/sex-matched controls. Cumulative incidence and mortality were evaluated within three time windows, then validated with Mendelian randomisation. Results showed a large short-term cancer increase and high early risk.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-incidence-and-mortality-among-patients-with-new-onset-atrial-fibrillation-a-population-based-matched-cohort-study/338488/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-incidence-and-mortality-among-patients-with-new-onset-atrial-fibrillation-a-population-based-matched-cohort-study/338488.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main question about atrial fibrillation and cancer?","Question",{"text":112,"@type":113},"The study examined the risk of cancer diagnosis and cancer mortality after a prior diagnosis of new-onset atrial fibrillation (AF).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants selected and what comparison was used?",{"text":117,"@type":113},"Linked electronic health records identified adults ≥18 with new-onset AF and age/sex-matched controls, forming a matched cohort for incidence and mortality analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about timing and magnitude of cancer risk?",{"text":121,"@type":113},"Within the first three months, cancer was diagnosed in 2.2% of AF patients versus 0.47% in controls, indicating a substantially higher short-term risk.",{"name":123,"@type":110,"acceptedAnswer":124},"Did Mendelian randomisation support a causal link between AF and cancer subtypes?",{"text":125,"@type":113},"Mendelian randomisation did not support a causal association between AF and major cancer subtypes.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},338488,1790113504,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Neoplasia 59 (2025) 101080  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>Cancer incidence and mortality among patients with new-onset atrial fibrillation: A population-based matched cohort study |  |  | |\n| --- | --- | --- | --- |\n| Nadine Zakkaka,b,*, Matthew Barclay a, Arturo Gonzalez-Izquierdoc,d,\u003Cbr>Amand Floriaan Schmidt e,f,g,h, Gregory Y.H. Lipi,j, Georgios Lyratzopoulosa, Rui Providencia d,ka Epidemiology of Cancer Healthcare and Outcomes Group (ECHO), Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, United Kingdom\u003Cbr>b Cancer intelligence, Cancer Research UK, London, United Kingdom\u003Cbr>c Centre for Health Data Science, Institute of Applied Health Research, University of Birmingham, United Kingdom d Institute of Health Informatics, University College London, United Kingdom\u003Cbr>e Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom f UCL British Heart Foundation Research Accelerator, London, United Kingdom\u003Cbr>g Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam UMC, the Netherlands h Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands\u003Cbr>i Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom\u003Cbr>j Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark k Barts Heart Centre, St Bartholomew’s Hospital, London, United Kingdom |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Atrial fibrillation Cancer Diagnosis Incidence\u003Cbr>Risk\u003Cbr>Mendelian randomisation |  | Background: Understanding the risk of cancer after the diagnosis of another condition can present opportunities for earlier diagnosis. We examined the risk of cancer diagnosis conditional on prior diagnosis of atrial fibrillation (AF).\u003Cbr>Methods: Linked electronic health records were used to identify patients aged ≥18 with new-onset AF and agesex-matched controls. Cumulative incidence of and mortality from cancer (overall and cancer-site specific) within three months, three months to five years and beyond five years from diagnosis of AF were examined. Findings were further validated using Mendelian randomisation (MR).\u003Cbr>Results: The cohort included 117,173 patients with new-onset AF and 117,173 matched controls (median age 78). In the first three months, 2.2% of AF patients were diagnosed with cancer vs. 0.47% in controls (relative risk: 4.7 [95%CI 4.2-5.4] in men and 4.4 [95%CI 3.8-5.0] in women). Nearly 80% of cancers related to thoracic or abdominal organs. Differences in cumulative incidence were only evident in women between three months and five years (subdistribution hazard ratio= 1.1 [95%CI 1.01-1.12]) and absent in all patients beyond five years. MR analysis did not support the presence of a causal association between AF and major cancer subtypes. Conclusion: There is a large short-term increase in cancer incidence and mortality following new-onset AF. The findings may reflect incidental identification of AF or paraneoplastic manifestation. New-onset AF confers high short-term risk of cancer diagnosis, at levels comparable with symptomatic risk threshold mandating urgent assessment for suspected cancer. |  |\n\nIntroduction  \nImprovements in chronic disease management mean more patients are developing multiple conditions. Atrial fibrillation (AF) is a common cardiac arrhythmia predicted to affect 17.9 million individuals in the European Union and UK by 2060.[1] Associations between AF and other  \ncardiovasc","cbCaivq9ksAMmShQ","https://ap.wps.com/l/cbCaivq9ksAMmShQ","pdf",2955335,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What was the study’s main question about atrial fibrillation and cancer?\",\"answer\":\"The study examined the risk of cancer diagnosis and cancer mortality after a prior diagnosis of new-onset atrial fibrillation (AF).\"},{\"question\":\"How were participants selected and what comparison was used?\",\"answer\":\"Linked electronic health records identified adults ≥18 with new-onset AF and age/sex-matched controls, forming a matched cohort for incidence and mortality analyses.\"},{\"question\":\"What did the study find about timing and magnitude of cancer risk?\",\"answer\":\"Within the first three months, cancer was diagnosed in 2.2% of AF patients versus 0.47% in controls, indicating a substantially higher short-term risk.\"},{\"question\":\"Did Mendelian randomisation support a causal link between AF and cancer subtypes?\",\"answer\":\"Mendelian randomisation did not support a causal association between AF and major cancer subtypes.\"}]","Cancer incidence and mortality among patients with new-onset atrial fibrillation - A population-based matched cohort study | PDF",1790023813,23,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcdfe742d78bc3a40a728f7ba83f0e7e.webp",983,1310,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb9c8e30f8f56827ff8bb899b1c8362d.webp",982,1309,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9f6193bbffa7176f27d29a52a8bbe3f.webp",981,1308,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b868f600c9c244244013e4b0c2e52474.webp",980,1306]